Rat Tumor Response to the Vascular-Disrupting Agent 5,6-Dimethylxanthenone-4-Acetic Acid as Measured by Dynamic Contrast-Enhanced Magnetic Resonance Imaging, Plasma 5-Hydroxyindoleacetic Acid Levels, and Tumor Necrosis-Reference-Cited by-同舟云学术

Rat Tumor Response to the Vascular-Disrupting Agent 5,6-Dimethylxanthenone-4-Acetic Acid as Measured by Dynamic Contrast-Enhanced Magnetic Resonance Imaging, Plasma 5-Hydroxyindoleacetic Acid Levels, and Tumor Necrosis

Published:2006-03 Issue:3 Volume:8 Page:199-206
ISSN:1476-5586
Container-title:Neoplasia
language:en
Short-container-title:Neoplasia

Author:

McPhail Lesley D.,McIntyre Dominick J.O.,Ludwig Christian,Kestell Philip,Griffiths John R.,Kelland Lloyd R.,Robinson Simon P.

Publisher

Elsevier BV

Subject

Cancer Research

Reference32 articles.

1. Vascular-targeting therapies for treatment of malignant disease;Siemann;Cancer,2004

2. Disrupting tumour blood vessels;Tozer;Nat Rev Cancer,2005

3. Endothelial-cell proliferation in experimental tumours;Denekamp;Br J Cancer,1982

4. The assessment of antiangiogenic and antivascular therapies in earlystage clinical trials using magnetic resonance imaging: issues and recommendations;Leach;BrJCancer,2005

5. Increased plasma serotonin following treatment with flavone-8-acetic acid, 5,6-dimethylxanthenone-4-acetic acid, vinblastine and colchicine: relation to vascular effects;Baguley;Oncol Res,1997

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of novel amidobenzimidazole derivatives as orally available small molecule modulators of stimulator of interferon genes for cancer immunotherapy;European Journal of Medicinal Chemistry;2023-12

2. Development of Potent Immune Modulators Targeting Stimulator of Interferon Genes Receptor;Journal of Medicinal Chemistry;2022-03-22

3. Non-Invasive Evaluation of Acute Effects of Tubulin Binding Agents: A Review of Imaging Vascular Disruption in Tumors;Molecules;2021-04-27

4. Recent Research on Flavonoids and their Biomedical Applications;Current Medicinal Chemistry;2021-04-01

5. Trial watch: STING agonists in cancer therapy;OncoImmunology;2020-01-01